newsfilter
← Latest News
GlobeNewswire·

Ernexa Therapeutics Provides Update on Operational Excellence and Performance

CAMBRIDGE, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today provided an update on its